🇺🇸 FDA
Pipeline program

Pirfenidone Solution for Inhalation

AP-LTE-008

Phase 2 small_molecule active

Quick answer

Pirfenidone Solution for Inhalation for Progressive pulmonary fibrosis [PPF] Idiopathic pulmonary fibrosis [IPF] is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Lacuna Pharma Pty Ltd
Indication
Progressive pulmonary fibrosis [PPF] Idiopathic pulmonary fibrosis [IPF]
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials